As expected, bicalutamide treatment caused a time-dependent decrease in the protein and mRNA levels of eIF5A2 and AR in androgen-dependent PCa cells, but not in AI PCa cells (Fig. 1E, F). The gene discussed is AR; the disease is posterior cortical atrophy.